|
Sydney Injecting Room: National Council seeks further advice
The Australian National Council on Drugs (ANCD), having considered
the 18 month evaluation of the Medically Supervised Injecting Centre
(MSIC) in Sydney, makes the following observations:
-
Kings Cross presents a unique set of community circumstances
and the particular MSIC model used may be inappropriate for
other locations;
-
whilst the evaluation itself is a careful analysis of the
work and outcomes of the MSIC, it is recognised that the estimates
of
lives saved and reduction of harms from the MSIC evaluation
are difficult to quantify, and that there are many issues involving
the work and outcomes of MSIC that warrant further investigation;
and
-
initiatives that save lives, reduce the risk of HIV, other
blood borne infections and diseases, and lead to improvements
in community
safety and well being, are deserving of support.
Given the limitations and difficulties in interpreting the MSIC
evaluation results, and noting the decision of the NSW Government
to continue to operate the MSIC as a trial, the ANCD will be referring
the MSIC report to a specialist committee for further review.
It is hoped that further evaluation will focus on the current MSIC
model’s capacity and appropriateness to engage with and potentially
refer clients to other health and welfare services, including drug
treatment agencies.
The ANCD also acknowledged that some members do not support injecting
centres because of a number of significant concerns, including
a view that such centres give a perception to the community that
drug use is condoned or accepted, and that there are cheaper and
more effective ways to engage those clients targeted by the MSIC.
Finally, the ANCD acknowledged the independent nature of the evaluation
and commended both the evaluation team and the staff of the MSIC
for their work in this difficult area.
The ANCD is the principal advisory body to Government on drug
and alcohol issues.
For further information, please contact:
Major Brian Watters (Chairman)
0400 780 509
Mr Gino Vumbaca (Executive Officer)
0408 244 552 or 02 6279 1650
Top of page
Home | About
ANCD | Current initiatives
| Publications | Media releases |
Meeting schedule | Asia-Pacific | NIDAC | Consultants register | Funding opportunities |
Drugs in Australia |
Links | Contact us
Whilst all care has been made to ensure only authorised
material appears on this site, the Australian National Council on
Drugs accepts no responsibility for inaccurate or false representations
appearing herein.
© Australian National Council on Drugs 2007
Web design by Starkis Design
|